The Science and Development team at APRINOIA Therapeutics focuses on advancing diagnostics and therapeutics for Alzheimer's disease and tauopathies. This team spearheads preclinical research, develops novel neurological treatments, and oversees the research and development operations to ensure innovative and effective healthcare solutions.
View all